Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Gemphire Therapeutics Inc (GEMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15904
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gemphire Therapeutics Inc (GEMP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead product Gemcabene (CI-1027), which is licensed from Pfizer is an oral therapy that targets known lipid metabolic pathways, lowering levels of LDL-C, inflammation and triglycerides. The company is evaluating gemcabene in clinical trials to enhance the clearance of very low-density lipoproteins (VLDLs) and to and inhibit the production of fatty acids and cholesterol in the liver. Gemphire is headquartered in Livonia, Michigan, the US.

Gemphire Therapeutics Inc Key Recent Developments

Mar 15,2019 Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Aug 13,2018 Gemphire Therapeutics reports second quarter 2018 financial results and provides corporate update
May 08,2018 Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03,2018 Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gemphire Therapeutics Inc – Key Facts
Gemphire Therapeutics Inc – Key Employees
Gemphire Therapeutics Inc – Key Employee Biographies
Gemphire Therapeutics Inc – Major Products and Services
Gemphire Therapeutics Inc – History
Gemphire Therapeutics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Gemphire Therapeutics Inc – Business Description
Gemphire Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Gemphire Therapeutics Inc – Strengths
Gemphire Therapeutics Inc – Weaknesses
Gemphire Therapeutics Inc – Opportunities
Gemphire Therapeutics Inc – Threats
Gemphire Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gemphire Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2019: Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Aug 13, 2018: Gemphire Therapeutics reports second quarter 2018 financial results and provides corporate update
May 08, 2018: Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03, 2018: Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
Mar 15, 2018: Gemphire Therapeutics Announces Fourth Quarter And Fiscal Year 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gemphire Therapeutics Inc, Key Facts
Gemphire Therapeutics Inc, Key Employees
Gemphire Therapeutics Inc, Key Employee Biographies
Gemphire Therapeutics Inc, Major Products and Services
Gemphire Therapeutics Inc, History
Gemphire Therapeutics Inc, Key Competitors
Gemphire Therapeutics Inc, Ratios based on current share price
Gemphire Therapeutics Inc, Annual Ratios
Gemphire Therapeutics Inc, Annual Ratios (Cont...1)
Gemphire Therapeutics Inc, Interim Ratios
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gemphire Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Gemphire Therapeutics Inc, Performance Chart (2014 - 2018)
Gemphire Therapeutics Inc, Ratio Charts
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fabchem China Limited (I54):企業概要、財務及び戦略的SWOT分析
    Summary Fabchem China Limited (Fabchem) is an investment holding company. The company produces and markets commercial explosive products. Its products include explosive devices, industrial fuse and initiating explosive devices, and industrial detonators. Fabchem’s explosive devices include boosters, …
  • FTS International Services, LLC-石油・ガス分野:企業M&A・提携分析
    Summary FTS International Services, LLC (FTSI) is a private oilfield services company. It provides a well completion services, including pressure pumping, wireline and reservoir optimization technologies. The company offers products and services to the exploration and production companies to enhance …
  • Atwood Oceanics, Inc. (ATW):企業の財務及び戦略的SWOT分析
    Atwood Oceanics, Inc. (ATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Excaliber Enterprises, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Excaliber Enterprises, Ltd. Mer …
  • BMC Software, Inc.:企業のM&A・提携・投資分析
    BMC Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BMC Software, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Shanghai East-China Computer Co., Ltd. (600850):企業の財務及び戦略的SWOT分析
    Summary Shanghai East-China Computer Co., Ltd. (Shanghai East) is a software solutions provider that focuses on value-added sales, professional services, solutions and innovative business area. The company offers wisdom education solutions, food and drug safety solutions, data center product solutio …
  • Aptose Biosciences Inc (APTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptose Biosciences Inc (Aptose) is a clinical-stage biotechnology company which focuses on diagnostics, therapies and treatment for patients with life-threatening cancers. The company advances in new therapeutics which focuses on cellular targets of cancer research coupled with companion dia …
  • Dogan Sirketler Grubu Holding A.S.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dogan Sirketler Grubu Holding A …
  • GIC Real Estate Pte., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GIC Real Estate Pte., Ltd. Merg …
  • China Pioneer Pharma Holdings Ltd (1345):企業財務及び戦略的SWOT分析
    Summary China Pioneer Pharma Holdings Ltd (Pioneer Pharma) is a medical equipment company that provides pharmaceutical products and medical devices. The company offers pharmaceutical products such as anti-inflammatory medicines, anti-coagulants, anti-asthma and COPD; intestinal cleaning agents, opht …
  • Jenson & Nicholson (India) Ltd (JENSONICOL):企業の財務及び戦略的SWOT分析
    Summary Jenson & Nicholson (India) Ltd (J&N) is a chemical company that manufactures paint and its products. The company manufactures and markets sectors of paint and varnishes. Its key products include designer finish, emulsions, distemper, enamels, texture paint, cement paint, enamels, wood coatin …
  • Aegean Marine Petroleum Network Inc. (ANW):企業のM&A・提携動向(石油・ガス分野)
    Summary Aegean Marine Petroleum Network Inc. (Aegean) is an oil and gas company that offers marine fuel logistics services. The company markets and offers refined marine fuels and lubricants to ships. It provides lubricants such as mineral, marine fuels, marine lubricants, cargo trading, synthetic a …
  • Waste Management, Inc. (WM)-エネルギー分野:企業M&A・提携分析
    Summary Waste Management, Inc. (Waste Management) is a provider of comprehensive waste management environmental services. It provides services such as collection, transfer, recycling and resource recovery, and disposal. The company also develops, operates and owns landfill gas-to-energy facilities i …
  • Pioneer Natural Resources Co (PXD):石油・ガス:M&Aディール及び事業提携情報
    Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activities i …
  • DEA Deutsche Erdoel AG:企業のM&A・提携動向(石油・ガス分野)
    Summary DEA Deutsche Erdoel AG (DEA), formerly RWE Dea AG, a subsidiary of Letterone Holdings S.A., oil and gas company that offers exploration and production services. The company explores and produces natural gas and crude oil. It offers exploration, drilling, hydraulic fracturing, extended reach …
  • Duraloy Technologies, Inc.:企業の戦略的SWOT分析
    Duraloy Technologies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • SBI Biotech Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SBI Biotech Co., Ltd. Mergers a …
  • Alcazar Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Alcazar Energy Ltd (Alcazar Energy) is a renewable energy company which develops and produces power generation projects with focus on solar photovoltaic (PV) and onshore wind technologies. The company specializes in origination, development, structuring, acquisition and operation of renewabl …
  • Grupo Aval Acciones y Valores S.A.:戦略・SWOT・企業財務分析
    Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Regeneron Pharmaceuticals, Inc. (REGN):企業の財務及び戦略的SWOT分析
    Regeneron Pharmaceuticals, Inc. (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆